Description
A secretolytic compound; decreases short-circuit current ex vivo in canine tracheal epithelium (IC50 = 39.4 nM) when applied submucosally; stimulates release of pulmonary surfactant (mucus), mucus protease inhibitor, IgG, and IgA; decreases viral survival and release of the cytokines TNF-α, IL-12, and interferon γ (IFN-γ) in the airway of a mouse model of H3N2 influenza infection (10 mg/kg per day); has antinociceptive activity; increases brain glucocerebrosidase activity
Formal name: trans-4-[[(2-amino-3,5-dibromophenyl)methyl]amino]-cyclohexanol, monohydrochloride
Synonyms: NA 872
Molecular weight: 414.6
CAS: 23828-92-4
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Antivirals||Product Type|Biochemicals|Ion Channel Modulation|Blockers||Research Area|Immunology & Inflammation||Research Area|Infectious Disease|Viral Diseases|Influenza||Research Area|Neuroscience|Neurodegenerative Disorders|Parkinson’s Disease||Research Area|Neuroscience|Pain Research